Unknown

Dataset Information

0

Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy.


ABSTRACT: MicroRNAs (miRNAs) open up a new field for molecular diagnosis for cancer and other diseases based on their stability in serum. However, the role of circulating miRNAs in plasma/serum in epilepsy diagnosis is still unclear. The aim of this study was to evaluate whether miRNAs can be used as biomarkers for drug-resistant epilepsy. We measured the differences in serum miRNA levels between 30 drug-resistant patients and 30 drug-responsive epilepsy patients in discovery and training phases using Illumina HiSeq2000 sequencing followed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) assays. The selected miRNAs were then validated in 77 drug-resistant epilepsy patients, 81 drug-responsive epilepsy patients and 85 healthy controls by qRT-PCR. We found that circulating miRNAs are differentially expressed between drug-resistant group and drug-responsive group. MiR-194-5p, -301a-3p, -30b-5p, -342-5p and -4446-3p were significantly deregulated in drug-resistant group compared to drug-responsive group and control group. Among these 5 miRNAs, miR-301a-3p had the best diagnostic value for drug-resistant epilepsy with 80.5% sensitivity and 81.2% specificity, and was negatively associated with seizure severity. These provide the rationale for further confirmation studies in larger prospective cohorts and in other ethnics.

SUBMITTER: Wang J 

PROVIDER: S-EPMC4435024 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy.

Wang Jun J   Tan Lan L   Tan Lin L   Tian Yan Y   Ma Jing J   Tan Chen-Chen CC   Wang Hui-Fu HF   Liu Ying Y   Tan Meng-Shan MS   Jiang Teng T   Yu Jin-Tai JT  

Scientific reports 20150518


MicroRNAs (miRNAs) open up a new field for molecular diagnosis for cancer and other diseases based on their stability in serum. However, the role of circulating miRNAs in plasma/serum in epilepsy diagnosis is still unclear. The aim of this study was to evaluate whether miRNAs can be used as biomarkers for drug-resistant epilepsy. We measured the differences in serum miRNA levels between 30 drug-resistant patients and 30 drug-responsive epilepsy patients in discovery and training phases using Ill  ...[more]

Similar Datasets

| S-EPMC8866954 | biostudies-literature
2022-01-20 | GSE193842 | GEO
| S-EPMC6679000 | biostudies-literature
| S-EPMC2657429 | biostudies-literature
| PRJNA798069 | ENA
| S-EPMC7882507 | biostudies-literature
| S-EPMC6305524 | biostudies-literature
| S-EPMC3907877 | biostudies-other
2020-09-11 | GSE157797 | GEO
| S-EPMC4186760 | biostudies-other